EAGLE_1 | R Documentation |
Kaplan-Meier digitized data from EAGLE, figure 1 (PMID 25908603). A reported sample size of 369 for a primary endpoint of PFS in colorectal cancer.
EAGLE_1
A data frame of 368 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (bev10, bev5) | |
Iwamoto S, Takahashi T, Tamagawa H, et al. FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study. Ann Oncol 2015; 26: 1427–33.
summary(EAGLE_1)
kmplot(EAGLE_1)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.